INTERNATIONAL PATENT: MYRIAD WOMEN'S HEALTH, INC. FILES APPLICATION FOR "TARGETED DEPLETION SEQUENCING FOR USE IN MINIMUM RESIDUAL DISEASE ASSAYS"

GENEVA, Jan. 27 -- MYRIAD WOMEN'S HEALTH, INC. (180 Kimball WaySouth San Francisco, California 94080) filed a patent application (PCT/US2025/037594) for "TARGETED DEPLETION SEQUENCING FOR USE IN MINIMUM RESIDUAL DISEASE ASSAYS" on Jul 14, 2025. With publication no. WO/2026/019737, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TRETTIN, Kyle (c/o Myriad Women's Health, Inc.180 Kimball WaySouth San Francisco, California 94080), MUZZEY, Dale E. (c/o Myriad Women's Health Inc.180 Kimball WaySouth San Francisco, California 94...